<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680234</url>
  </required_header>
  <id_info>
    <org_study_id>Alopecia2020</org_study_id>
    <nct_id>NCT04680234</nct_id>
  </id_info>
  <brief_title>Superficial Cryotherapy Versus Microneedling in Alopecia Areata</brief_title>
  <official_title>Comparative Study Between the Effect of Superficial Cryotherapy Using Dimethyl Ether and Propane Mixture and Microneedling in Treatment of Alopecia Areata</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is randomized comparative analytical prospective study that included patients with&#xD;
      mild and moderate alopecia areata. Patients was divided into two groups Patients in the first&#xD;
      group underwent Superficial cryotherapy using dimethyl ether and propane (DMEP) at -57C&#xD;
      (Cryotherapy group). Patients in the second group underwent Microneedling (Microneedling&#xD;
      group). A total of six sessions were done at 2 weeks interval. Patients were followed-up for&#xD;
      next 3 months to evaluate the persistence of hair regrowth after therapy. Patients were&#xD;
      assessed at baseline and during follow up using photography, Dermoscopy, SALT score and&#xD;
      regrowth scale.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be divided into two groups (randomly assigned and comparably cross matched for age and sex) Cryotherapy group (No.= 50): Superficial cryotherapy using dimethyl ether and propane (DMEP) at -57C Microneedling group (No. = 50): Microneedling</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Regrowth Scale</measure>
    <time_frame>Change in regrowth scale from baseline to 3 months follow after end of sessions</time_frame>
    <description>0 score (regrowth &lt; 10%) no response&#xD;
score (regrowth 11-25%) poor response&#xD;
score (regrowth 26-50%) fair response&#xD;
score (regrowth 51-75%) satisfactory response&#xD;
score (regrowth ≥ 75%) excellent response.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SALT score</measure>
    <time_frame>Change in salt score from baseline to 3 months follow after end of sessions</time_frame>
    <description>SALT score is the sum of the percentage of hair loss in all the abovementioned areas. For example, if the percentage hair loss in vertex, right profile, left profile, and posterior aspect is 20, 30, 40, and 50% respectively; then, SALT score = (20 × 0.4) = (30 × 0.18) + (40 × 0.18) + (50 × 0.24) = 8 + 5.4 + 7.2 + 12 = 32.6.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Alopecia Areata</condition>
  <arm_group>
    <arm_group_label>Cryotherapy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients underwent superficial cryotherapy using dimethyl ether and propane (DMEP) at -57C very 2 weeks for maximum six sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microneedling group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients underwent microneedling 2 weeks for maximum six sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DMEP kit</intervention_name>
    <description>Superficial Cryotherapy using dimethyl ether and propane (DMEP) at -57C</description>
    <arm_group_label>Cryotherapy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dermapen</intervention_name>
    <description>Under aseptic precautions, the dermapen was moved on the alopecic patches diagonally, vertically and horizontally 4 to 5 times in each direction Pin point bleeding was taken as an end point</description>
    <arm_group_label>Microneedling group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ِAlopecia areata patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Alopecia totalis and universalis&#xD;
&#xD;
          -  ِAge less than four years.&#xD;
&#xD;
          -  ِPregnancy or breast-feeding.&#xD;
&#xD;
          -  ِActive infection at the site alopecia patch(s).&#xD;
&#xD;
          -  ِInflammation ate site of the alopecia patches&#xD;
&#xD;
          -  ِIntolerance to cold.&#xD;
&#xD;
          -  ِAssociated systemic illness such as thyroid, pernicious anaemia, diabetes mellitus,&#xD;
             autoimmune connective tissue diseases.&#xD;
&#xD;
          -  ِPrevious treatment for alopecia areata over the last three months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeinab A Gouda, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Sohag Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sohag Faculty of Medicine</name>
      <address>
        <city>Sohag</city>
        <zip>52324</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>December 20, 2020</last_update_submitted>
  <last_update_submitted_qc>December 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Zeinab Abu elbaha Gouda</investigator_full_name>
    <investigator_title>Assistant lecturer of Dermatology, Venereology and Andrology</investigator_title>
  </responsible_party>
  <keyword>alopecia areata</keyword>
  <keyword>Microneedling</keyword>
  <keyword>Cryotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>data will be provided upon request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Always</ipd_time_frame>
    <ipd_access_criteria>Request to prinicipal investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

